Source: Annual Congress 2005 - COPD - staging and therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Anderson, M. McLaughlin, E. Drost, W. MacNee (Edinburgh, United Kingdom). Role of inhaled antioxidants in chronic obstructive pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 4576

Member's Comments

No comment yet.

Related content which might interest you: Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Inhaled budesonide in the management of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Application of erdosteine in the treatment of occupational chronic obstructive pulmonary disease Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Inhaled corticosteroids and survival in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 202-203 Year: 2003 Antioxidant properties of ambroxol in chronic obstructive pulmonary disease Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2014; 65: 1-17 Year: 2014 Chronic obstructive pulmonary disease Source: Eur Respir Mon; 2009: 45: 25–31 Year: 2009 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2013; 62: 1-18 Year: 2013 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2015; 70: 80-98 Year: 2015